Tag: OTC:IPATF

March 2, 2020

ImmunoPrecise Announces AI Collaboration with EVQLV for Coronavirus

IMMUNOPRECISE and EVQLV are collaborating on accelerating the global effort to develop lead vaccine candidates against the SARS-CoV-2 virus.